Literature DB >> 11042439

The kings schizotypy questionnaire as a quantitative measure of schizophrenia liability.

L A Jones1, A G Cardno, K C Murphy, R D Sanders, M Y Gray, G McCarthy, P McGuffin, M J Owen, J Williams.   

Abstract

We used a new self-report measure, the Kings Schizotypy Questionnaire (KSQ; Williams, M. The psychometric assessment of schizotypal personality. PhD thesis. Institute of Psychiatry, University of London, 1993), to investigate schizotypy as a quantitative measure of familial liability to schizophrenia. The KSQ was administered to 135 DSM-IV schizophrenia probands, 153 of their healthy first-degree relatives, and 267 control subjects. We found that the questionnaire clearly differentiated schizophrenic from non-schizophrenic individuals, but failed to differentiate the relatives from controls. Possible reasons for this include defensive responding among relatives, self-selection bias among relatives, differences in data collection methods, and the possibility that positive aspects of schizotypy may not be closely related to familial liability to schizophrenia.

Entities:  

Mesh:

Year:  2000        PMID: 11042439     DOI: 10.1016/s0920-9964(99)00183-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

Review 1.  Genetic Consideration of Schizotypal Traits: A Review.

Authors:  Emma E Walter; Francesca Fernandez; Mollie Snelling; Emma Barkus
Journal:  Front Psychol       Date:  2016-11-15

2.  Psychosocial markers of age at onset in bipolar disorder: a machine learning approach.

Authors:  Sorcha Bolton; Dan W Joyce; Katherine Gordon-Smith; Lisa Jones; Ian Jones; John Geddes; Kate E A Saunders
Journal:  BJPsych Open       Date:  2022-07-18

3.  Postpartum psychosis in bipolar disorder: no evidence of association with personality traits, cognitive style or affective temperaments.

Authors:  A Perry; K Gordon-Smith; I Webb; E Fone; A Di Florio; N Craddock; I Jones; L Jones
Journal:  BMC Psychiatry       Date:  2019-12-12       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.